The market in the USA was about nil anyway so they probably label any shipments "for research only" and avoid maintaining the registration.
The fees vary from year to year and are based on the FDA's cost of ongoing facility inspections, etc., divided by the number of approved products. Radient's business probably would not pass a facilities inspection anyway.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.